Floatz logo

RETEPLASE, RECOMBINANT

Basilar Artery Occlusion

The First Affiliated Hospital of University of Science and Technology of Chinaprotein_peptidePhase 3Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Basilar Artery Occlusion cohort.

Asset / SponsorPhaseRating
Tenecteplase
Xuanwu Hospital, Beijing
Phase 4BBB
Recombinant Human Plasminogen Activator
The First Affiliated Hospital of University of Science and Technology of China
Phase 3BB
Arestin
Xijing Hospital
Phase 4BB
Tirofiban
The First Affiliated Hospital of University of Science and Technology of China
Phase 3BB
Prourokinase
The First Affiliated Hospital of University of Science and Technology of China
Phase 3B
Cerebrolysin
University Hospital Sestre Milosrdnice
Early Phase 1C
PROPRANOLOL
Xuanwu Hospital, Beijing
N/AD

Same molecule, other indications

RETEPLASE, RECOMBINANT is also rated in:

Acute Ischemic StrokeDormant
B
Indicative ·
63 / 100
View asset →
stroke disorderDormant
B
Indicative ·
57 / 100
View asset →
StrokeDormant
B
Indicative ·
56 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →